Cory Renauer

Cory Renauer has been a contributing Healthcare Analyst at The Motley Fool since 2013. He won't give you personalized investing advice.

[Cory Renauer @coryrenauer]

Looks like @GrandViewInc hired ChatGepetto to do its research reports. You can pay just under $6K for a license to view a report that estimates the total surgical robot market at $4.3 billion in 2024. $ISRG alone reported $8.35 billion in sales last year! https://t.co/awIpgxR85o

[Cory Renauer @coryrenauer]

@RuxandraTeslo Just look at Nektar's chart going back a decade or three. Nothing weird about investors being afraid of getting burned again by a decades-old biotech that's still losing over 9 figures annually.

[Cory Renauer @coryrenauer]

Is Pfizer stock a yield trap? https://t.co/PEl1wKUwz7 $PFE #dividends

[Cory Renauer @coryrenauer]

Progress? "The vehicle suddenly accelerated with our baby in it."
https://t.co/NhroUHxJNy

[Cory Renauer @coryrenauer]

"about 4,000 complaints on sudden acceleration or phantom braking." https://t.co/IvABZsBpaE

[Cory Renauer @coryrenauer]

These Are the Best Stocks You Can Buy With $1,000 Right Now https://t.co/tBZxIhRvRG $NVDA $LRCX $ASML

[Cory Renauer @coryrenauer]

Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now? $EDIT https://t.co/ekRGNDQCoZ

[Cory Renauer @coryrenauer]

@Sports_bios At least "simufilam continued to demonstrate an overall favorable safety profile."

[Adam Feuerstein ✡️ @adamfeuerstein]

In light of the $SAVA outcome, please consider subscribing to STAT.

Link here. https://t.co/CZ7wOkt0Tx

Use the code ADAM25 for a special discount.

My colleagues and I work hard every day to deliver important, valuable reporting from biotech and across healthcare. Becoming a subscriber to STAT helps support our journalism. Thank you!

[Cory Renauer @coryrenauer]

Just incredible

[Simon Erickson @7Innovator]

Matt's coverage of Cassava $SAVA is absolutely incredible.

If you're an investor in the stock -- or even if you're just interested in the company -- he is a must-follow here on Twitter.

[dough @semodough]

$VKTX VK2735 BEST in Class. DATA looks like against its competition

[dough @semodough]

$VKTX - important nugget today that most traders have no idea on - but others should know about - monthly dosing - will be game changer in Maintenance market - $VKTX providing proof first time why they can do it

[Cory Renauer @coryrenauer]

Bezos claims that people who care about journalism have no choice but to accept his decisions and excuses — and trust his benevolent leadership. https://t.co/dQnVVlJTze

[Cory Renauer @coryrenauer]

@TravisHoium @GuyDealership I swear Tata's tanking Jauar on purpose to spite Britain

[Cory Renauer @coryrenauer]

@TravisHoium It better. My $SOFI position is finally in the green and I'd like it to stay that way.

[Cory Renauer @coryrenauer]

Anybody else hear "Peg see Taco plan" in their head when they look at pegcetacoplan from Apellis? $APLS

[Paras Sharma @paras_biotech]

XBI's strength many times depends on M&A's momentum - as shown by RBC's analysis below

[Dirty Texas Hedge @HedgeDirty]

The top reason I am distrustful of the crypto ecosystem is that the promoters either don't realize they are re-inventing long-established features of traditional finance and are ignorant of the problems that will have to be managed, or they do know it and are blase about them

[Jesse Joyce @jessejoyce]

I wrote this cause it’s what I always wanted to say about Trump pretending to be a tough guy.  But we got the amazing @DaveBautista to say it SO much better.  Thanks Dave.  #TrumpIsAWeakLittleBabyBitch